A preliminary study finds that the SARS-CoV-2 vaccine from Pfizer and BioNTech is effective against a viral variant recently identified among strains in the UK and South Africa, the Associated Press reports.
A preliminary study finds that the SARS-CoV-2 vaccine from Pfizer and BioNTech is effective against a viral variant recently identified among strains in the UK and South Africa, the Associated Press reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.